Craft

Advanced
Almirall

Almirall

Stock Price

€9.2

2024-10-29

Market Capitalization

€2 B

2024-10-29

Revenue

€1.1 B

FY, 2025

Almirall Summary

Company Summary

Overview
Almirall is a biopharmaceutical company that specializes in medical dermatology. It offers research and development solutions, digital health services, pharmaceutical products for skin health, etc.
Type
Public
Status
Active
Founded
1943
HQ
Barcelona, ES | view all locations
Website
https://www.almirall.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Table of Contents

Key People

  • Carlos Gallardo Piqué

    Carlos Gallardo Piqué, President & Chief Executive Officer, Chairman and Executive Director

  • Enrique de Leyva Pérez

    Enrique de Leyva Pérez, Vice Chair and Lead Independent Director

    • Seth J. Orlow

      Seth J. Orlow, Independent Director

      • Eloi Crespo Cervera

        Eloi Crespo Cervera, Chief Industrial Operations Officer

      LocationsView all

      1 location detected

      • Barcelona, Catalunya HQ

        Spain

        151 Ronda del General Mitre

      Almirall Financials

      Summary Financials

      Revenue (FY, 2025)
      €1.1B
      Gross profit (FY, 2025)
      €851.3M
      Net income (FY, 2025)
      €46.2M
      Cash (FY, 2025)
      €337.8M
      EBIT (FY, 2025)
      €73.3M
      Enterprise value
      $1.9B

      Competitors and Similar Companies

      Compare competitors

      Footer menu

      Product

      Solutions

      Resources

      Company

      © Craft.co 2026
      Share price data provided by IEX